Alignment Healthcare, Inc. - COMMON STOCK (ALHC)

CUSIP: 01625V104

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+1,171,017
Put/Call ratio
2.8%
SEC-reported price per share
$4.96
Number of holders
126
Value change
-$12,956,614
Number of buys
63
Open additional details 1 more signal available
Number of sells
60
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
207,490,899

Security key

01625V104

Report period

Q1 2024

Institutions

126

Top holders

10

Ownership snapshot

Top reported holders of ALHC - Alignment Healthcare, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WARBURG PINCUS LLC
Disclosed value leader
GENERAL ATLANTIC, L.P.
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F 3/4/5 Highest disclosed value: $525,152,511 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

GENERAL ATLANTIC, L.P. has the largest disclosed position value at $525.15M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GENERAL ATLANTIC, L.P.'s linked filing trail.
Disclosed position value Top 5
WARBURG PINCUS LLC $154.32M
Warburg Pincus Partners GP LLC $151.63M
GENERAL ATLANTIC, L.P. $525.15M
T. Rowe Price Investment Manageme... $103.97M
VANGUARD GROUP INC $78.75M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WARBURG PINCUS LLC
13F 3/4/5
Company · Director, 10%+ Owner
—
denominator unverified
$154,315,127
17,922,779 shares
— 31 Dec 2023
Warburg Pincus Partners GP LLC
3/4/5
Director, 10%+ Owner
—
denominator unverified
$151,626,710
17,922,779 shares
— 20 Sep 2022
GENERAL ATLANTIC, L.P.
13F
Company
13F
—
denominator unverified
$525,152,511
60,993,323 shares
— 31 Dec 2023
T. Rowe Price Investment Management, Inc.
13F
Company
13F
—
denominator unverified
$103,971,000
12,075,504 shares
— 31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$78,748,868
9,146,210 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$62,640,781
7,275,352 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
126
Shares
163,953,772
Rows available
126
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
126
Q1 2024 holders
126
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .